Catalyst Wire Dossier Catalyst Wire Dossier

Kengrexal

cangrelor · Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kengrexal, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: EMA Authorised: Kengrexal (cangrelor) — Chiesi Farmaceutici S.p.A.

See pricing